Tci Gene (ROCO:6879) Interest Expense : NT$-1.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tci Gene's interest expense for the six months ended in Dec. 2023 was NT$ -0.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-1.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tci Gene's Operating Income for the six months ended in Dec. 2023 was NT$ 4.3 Mil. Tci Gene's Interest Expense for the six months ended in Dec. 2023 was NT$ -0.6 Mil. Tci Gene's Interest Coverage for the quarter that ended in Dec. 2023 was 7.58. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tci Gene Interest Expense Historical Data

The historical data trend for Tci Gene's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Interest Expense Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.07

-0.84

-0.85

-1.18

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial				-0.84	-0.70	-0.15	-0.62	-0.57

Tci Gene Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.2 Mil.

Tci Gene (ROCO:6879) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tci Gene's Interest Expense for the six months ended in Dec. 2023 was NT$-0.6 Mil. Its Operating Income for the six months ended in Dec. 2023 was NT$4.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was NT$0.0 Mil.

Tci Gene's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	4.281	/	-0.565
	=	7.58

The higher the ratio, the stronger the company's financial strength is.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines